What is Kiora Pharmaceuticals, Inc. Common Stock's Market Cap?

Kiora Pharmaceuticals, Inc. Common Stock's Market Cap is $11.2M, based on as-reported figures from SEC (XBRL) filings.

What is Kiora Pharmaceuticals, Inc. Common Stock's Enterprise Value?

Kiora Pharmaceuticals, Inc. Common Stock's Enterprise Value is -$5.6M, based on as-reported figures from SEC (XBRL) filings.

What is Kiora Pharmaceuticals, Inc. Common Stock's EV / EBITDA?

Kiora Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 0.4×, based on as-reported figures from SEC (XBRL) filings.

What is Kiora Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?

Kiora Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Kiora Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?

Kiora Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$11.0M, based on as-reported figures from SEC (XBRL) filings.

What is Kiora Pharmaceuticals, Inc. Common Stock's EBITDA?

Kiora Pharmaceuticals, Inc. Common Stock's EBITDA is -$12.8M, based on as-reported figures from SEC (XBRL) filings.

What is Kiora Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?

Kiora Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -2.48, based on as-reported figures from SEC (XBRL) filings.

What is Kiora Pharmaceuticals, Inc. Common Stock's Net Debt?

Kiora Pharmaceuticals, Inc. Common Stock's Net Debt is -$16.8M, based on as-reported figures from SEC (XBRL) filings.

Kiora Pharmaceuticals, Inc. Common Stock (KPRX) Financial Statements

Kiora Pharmaceuticals, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG0083Y1Q78

XNAS · usd

2.54▲ 0.03 (1.20%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close2.51

Day's Range2.49 – 2.64

52-Week Range1.74 – 2.95

Volume9,540

Avg Volume14.5K

Share Statistics

Shares Outstanding

Employees13

ExchangeXNAS

Listed2015-02-13

Share count as of August 5, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Kiora Pharmaceuticals, Inc. Common Stock (KPRX)

What is Kiora Pharmaceuticals, Inc. Common Stock's Market Cap?: Kiora Pharmaceuticals, Inc. Common Stock's Market Cap is $11.2M, based on as-reported figures from SEC (XBRL) filings.
What is Kiora Pharmaceuticals, Inc. Common Stock's Enterprise Value?: Kiora Pharmaceuticals, Inc. Common Stock's Enterprise Value is -$5.6M, based on as-reported figures from SEC (XBRL) filings.
What is Kiora Pharmaceuticals, Inc. Common Stock's EV / EBITDA?: Kiora Pharmaceuticals, Inc. Common Stock's EV / EBITDA is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Kiora Pharmaceuticals, Inc. Common Stock's Revenue (TTM)?: Kiora Pharmaceuticals, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Kiora Pharmaceuticals, Inc. Common Stock's Net Income (TTM)?: Kiora Pharmaceuticals, Inc. Common Stock's Net Income (TTM) is -$11.0M, based on as-reported figures from SEC (XBRL) filings.
What is Kiora Pharmaceuticals, Inc. Common Stock's EBITDA?: Kiora Pharmaceuticals, Inc. Common Stock's EBITDA is -$12.8M, based on as-reported figures from SEC (XBRL) filings.
What is Kiora Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM)?: Kiora Pharmaceuticals, Inc. Common Stock's Diluted EPS (TTM) is -2.48, based on as-reported figures from SEC (XBRL) filings.
What is Kiora Pharmaceuticals, Inc. Common Stock's Net Debt?: Kiora Pharmaceuticals, Inc. Common Stock's Net Debt is -$16.8M, based on as-reported figures from SEC (XBRL) filings.